Sexual dysfunction in patients under dialytic treatment

Minerva Urologica e Nefrologica

Volumn 58, Issue 2, 2006, Pages 195-200

  Dachille, G ^a,c   Pagliarulo, V ^a   Ludovico, G M ^a   Ralph, D ^b   Pagliarulo, A ^a  

^a POLICLINICO   (Italy)

^b INSTITUTE OF UROLOGY AND NEPHROLOGY   (United Kingdom)

^c Clinica Urologica II   (Italy)

Author keywords

Apomorphine; Dialysis; Erectile dysfunction; Sildenafil

Indexed keywords

APOMORPHINE; SILDENAFIL;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERECTILE DYSFUNCTION; HEMODIALYSIS PATIENT; HUMAN; MEDICAL LITERATURE; RISK FACTOR; SEXUAL DYSFUNCTION;

ADULT; AGED; APOMORPHINE; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 33745482553     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kawano T. Sexual dysfunction. Nippon Rinsho 1997;55:3025-9. Japanese.
2. Bommer J, Ritz E, del Pozzo E, Bommer G. Improved sexual function in male haemodialysis patients on bromocriptine. Lancet 1979;8:2:496-7.
3. Procci WR, Goldstein DA, Aldestein J, Massry SG. Sexual dysfunction in the male patient with uremia: a reappraisal. J Kidney Int 1981;19:317-23.
4. Rodger RS, Fletcher K, Dewar JH, Genner D, McHugh M, Wilkinson R et al. Prevalence and pathogenesis of impotence in one hundred uremic men. Uremia Invest 1984-85;8:89-96.
5. Bellingeri G, Santoro D, Lo Forti B, Mallamance A, De Santo RM, Savica V. Erectile dysfunction in uremic dialysis patients: diagnostic evalutation in the sildenafil era. Am J Kidney Dis 2001;38 (4 Suppl 1):S115-7.
6. Rodger RS, Sheldon WL, Wastson MJ, Dewar JH, Wilkinson R, Ward MK et al. Zinc deficiciency and hyperprolactinemia are not reversibile causes of sexual dysfunction in uremia. Nephrol Dial Transplant 1989;4:888-92.
7. Lawrence IG, Prince DE, Howlett TA, Harris KP, Feehally J, Walls J. Erythropoietin and sexual dysfunction. Nephrol Dial Transplant 1997;12:714-7.
8. Lawrence IG, Prince DE, Howlett TA, Harris KP, Feehally J, Walls J. Correcting impotence in the male dialysis patient experience with testosterone replacement and vacuum tumescence therapy. Am J Kidney Dis 1998;31:313-9.
9. Ahuja SK, Krane NK, Heellstrom WJ. Penile prothesese in the management of impotence in patients with end stage renal disease. J La State Med Soc 1998;150:32-4.
10. Chen J, Mabjeesh NJ, Greenstein A, Nadu A, Matzkin H. Clinical efficacy of sildenafil in patients on chronic dialysis. J Urol 2001;65:819-21.
11. Gil A, Martinez E, Oyaguez I, Palacios G, Rejas J. Erectile dysfunction in a primary care setting: results of a observational, no-control-group, prospective study with silde under routine conditions of use. Int J Impot Res 2001;13:338-47.
12. Kurata K, Shibata R. Effects of D1 and D2 antagonists on the transient increase of dopamine release by dopamine agonists by means of brain dialysis. Neurosci Lett 1991;133:77-80.
13. Juergenge PH, Botev R, Wuerth D, Finkelstein SH, Smith JD, Finkelstein FO. Erectile dysfunction in chronic peritoneal dialysis patients: incidence and treatment with sildenafil. Perit Dial Int 2001;21:355-9.
14. Foulks CJ, Cushner HM. Sexual dysfunction in the male dialysis patient: pathogenesis, evalutation, and therapy. Am J Kidney Dis 1986;8:211-22.
15. YenicerioGlu Y, Kefi A, Aslan G, Cavdar C, Esen AA, Casari T et al. Efficacy and safety of sildenafil for treating erectile dysfunction in patients on dialysis. BJU Int 2002;90:442-5.
16. Lawrence IG, Price DE, Howlett TA, Harris KP, Feehally J, Walls J Erythropoietin and sexual dysfunction. Nephrol Dial Transplant 1997;12:741-7.
17. Naya Y, Soh J, Ochiai A, Mizutani Y, Ushijima S, Kamoi K et al. Significant decrease of the international index of erectile function in male failure patients treated with hemodialysis. Int J Impot Res 2002;14:172-7.